Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.2.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-5377.88China
JN.1.65ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-5377.88China
GM.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-5385.48Hong Kong
B.51ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-5424.4Singapore
B.1.267NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-5467.16Germany
B.1.444NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-5467.16Germany
B.1.1.74NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-5467.16Germany
BM.1.1.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
XSORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BA.1.9ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
MB.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BA.5.2.54ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
ED.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
CM.4ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BQ.1.4ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BN.1.9ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BU.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BQ.1.23ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
AY.52 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
FL.20.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
JN.1.30NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
JR.1.1.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
XDENCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
JN.1.1.9NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
GW.5NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
GJ.1.2.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
DV.7.1.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
GW.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
HY.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
XBB.1.5.42NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
JN.1.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
JN.1.9NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
HK.24.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
GK.2.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.587NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.333NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
GK.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
HN.6NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
JY.1.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
AY.4.6 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
BE.1.3NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
BA.2 (Omicron)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
AZ.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.6NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.33NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
AZ.3NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
AY.121.1 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.4.8NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
AZ.5NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
GK.1.11.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used